| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/18/2011 | CN101490007B VR1 vanilloid receptor antagonists with a iononic substructure |
| 05/18/2011 | CN101475527B Method for preparing isonicotinic acid and pyrazinamide by non-catalytic hydrolyzing isonicotinonitrile in near-critical water medium |
| 05/18/2011 | CN101282933B Novel NK1 and NK2 antagonists |
| 05/18/2011 | CN101177557B Small particle copper pyrithione |
| 05/18/2011 | CN101052634B Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 05/17/2011 | US7943803 Clathrate compound, method for controlling concentration of aqueous agricultural chemical active ingredient solution, and agricultural chemical formulation |
| 05/17/2011 | US7943776 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 05/17/2011 | US7943768 Piperazine compounds useful as antagonists of C-C chemokines (Ccr2b and CcrS) for the treatment of inflammatory diseases |
| 05/17/2011 | US7943643 Aryl substituted pyridines and the use thereof |
| 05/17/2011 | US7943630 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/17/2011 | CA2473790C 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 05/17/2011 | CA2463552C Treatment of neurodegenerative diseases and cancer of the brain |
| 05/17/2011 | CA2453418C Variolin derivatives and their use as antitumor agents |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
| 05/12/2011 | WO2011055914A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 05/12/2011 | WO2011055843A1 Retinoid compound |
| 05/12/2011 | WO2011055819A1 Catalyst for production of bisphenol compound and method for producing bisphenol compound |
| 05/12/2011 | WO2011055057A1 Method for synthesizing bio-based pyridine and picolines |
| 05/12/2011 | WO2011054530A1 Gpbp inhibition using q2 peptidomimetics |
| 05/12/2011 | WO2010065906A3 Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
| 05/12/2011 | US20110112152 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors |
| 05/12/2011 | US20110112151 Compound capable of inhibiting 11-beta hydroxysteriod dehydrogenase |
| 05/12/2011 | US20110112140 Inhibitor of plasminogen activator inhibitor-1 |
| 05/12/2011 | US20110112114 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 05/12/2011 | US20110112076 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/12/2011 | US20110110914 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 05/12/2011 | US20110108755 Heteroaromatic phthalonitriles |
| 05/12/2011 | CA2780149A1 Ire-1.alpha. inhibitors |
| 05/12/2011 | CA2780128A1 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 05/12/2011 | CA2778922A1 Process for the preparation of pyrazinone thrombin inhibitor and its intermediates |
| 05/12/2011 | CA2774043A1 Prolyl hydroxylase inhibitors |
| 05/11/2011 | EP2319890A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
| 05/11/2011 | EP2319834A1 Methods and devices for the production of aqueous solutions of cyanopyridines |
| 05/11/2011 | EP2319833A1 Methods and devices for the production of aqueous solutions of cyanopyridines |
| 05/11/2011 | EP2319830A1 Amide derivative, pest control agent containing the amide derivative and use of the pest control agent |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2318370A1 Fluorinated heteroaryls |
| 05/11/2011 | EP2318369A1 Squaric acid derivatives as inhibitors of the nicotinamide |
| 05/11/2011 | EP2318368A1 1-(4-ureidobenzoyl)piperazine derivatives |
| 05/11/2011 | EP2318366A2 Psma-binding agents and uses thereof |
| 05/11/2011 | EP2318361A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 05/11/2011 | EP1320520B1 Sulfonylguanidine |
| 05/11/2011 | CN201825896U Novel pentachloropyridine production device |
| 05/11/2011 | CN1696116B 0-(5,6,7,8-tetrahydro-2-naphthyl)-N-(6-methoxy group-2-pyridyl)-N-methyl methyl thiocarbamate and its preparation method |
| 05/11/2011 | CN102057514A Organic electroluminescent element |
| 05/11/2011 | CN102056897A Sulfonamide compound and application thereof |
| 05/11/2011 | CN102050779A Method for preparing 2-mercaptopyridine |
| 05/11/2011 | CN102050759A Resveratrol amide derivative and preparation method thereof |
| 05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
| 05/11/2011 | CN102050747A Preparation method of organic onium tetrafluoroaluminate and method for preparing aluminum oxide through low temperature electrolysis |
| 05/11/2011 | CN102050689A Method for preparing beta-amino-alpha,beta unsaturated ester |
| 05/11/2011 | CN102050687A Method for preparing aromatic primary amine by taking ammonia water as ammonia source in water phase system |
| 05/11/2011 | CN102049213A Propargyl alcohol type quaternary ammonium salt surfactant and preparation method thereof |
| 05/11/2011 | CN101723884B Preparation method of 2-chloro -3-trifluoroethoxy pyridine |
| 05/11/2011 | CN101602711B Microporous coordination polymer material based on 4-(4-pyridyl) acidum benzoicum and preparation method and application thereof |
| 05/11/2011 | CN101497610B Dithiazole ethylene compound containing 2,1,3-diazosulfide unit |
| 05/11/2011 | CN101121695B Method for preparing nitrogen-containing onium salt compounds |
| 05/10/2011 | US7939697 Fluorinating agent and method for producing fluorine-containing compound using the same |
| 05/10/2011 | US7939666 Enzyme inhibitors |
| 05/10/2011 | US7939552 Benzyloxypropylamine derivative |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | US7939548 Certain chemical entities, compositions, and methods |
| 05/10/2011 | US7939542 Cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same and a pharmaceutical composition comprising the same |
| 05/10/2011 | US7939533 Dual NK1/NK3 receptor antagonists |
| 05/10/2011 | US7939532 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 05/10/2011 | CA2621805C Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
| 05/10/2011 | CA2487388C Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
| 05/10/2011 | CA2486675C Gelling agents |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2457950C Pyridinium-betain compounds as taste enhancer |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 05/05/2011 | WO2011053948A1 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals |
| 05/05/2011 | WO2011053582A1 Improved silver cathode activation |
| 05/05/2011 | WO2011051671A1 Aminopyridine derivatives as kallikrein inhibitors |
| 05/05/2011 | WO2011051535A1 Bis(aralkyl)amino and six membered (hetero)aromatic system derivatives and the use thereof in the treatment of neurodegenerative pathological conditions, including alzheimer's disease |
| 05/05/2011 | WO2011051282A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis |
| 05/05/2011 | WO2011051201A1 Positive allosteric modulators (pam) |
| 05/05/2011 | WO2010139585A3 Crystalline phases of 2'-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide |
| 05/05/2011 | WO2010069494A8 Use of 5-pyridin-4yl(1,3)thiazole for treating phytopathogenic fungi |
| 05/05/2011 | WO2005060456A9 Method for treating adamts-5-associate disease |
| 05/05/2011 | US20110105760 Method for Producing Aminobiphenylene |
| 05/05/2011 | US20110105758 Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroarylcarbocyclic acids |
| 05/05/2011 | US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 05/05/2011 | US20110105571 Opioid Receptor Antagonists |
| 05/05/2011 | US20110105566 Fungicide hydroximoyl-tetrazole derivatives |
| 05/05/2011 | US20110105545 GPBP inhibition using Q2 peptidomimetics |
| 05/05/2011 | US20110105544 Carboxylic derivatives for use in the treatment of cancer |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105532 Haloalkyl-substituted amides as insecticides and acaricides |
| 05/05/2011 | US20110105486 Thiazole derivatives |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105482 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders |
| 05/05/2011 | US20110104276 Pharmaceutical composition containing as an active ingredient 5-methyl-1-phenyl-2-(1h)-pyridone |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/05/2011 | CA2779268A1 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals |
| 05/05/2011 | CA2778219A1 Positive allosteric modulators (pam) |
| 05/05/2011 | CA2777671A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis |
| 05/04/2011 | EP2316826A1 Pyridazine derivatives and their use as therapeutics agents |